search
Back to results

Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy

Primary Purpose

Polyps

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tissue Apposition System (TAS) Device
Sponsored by
Ethicon Endo-Surgery
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Polyps focused on measuring colon, rectum, polyp, EMR, Established indication for a procedure greater than colonoscopy and colonic polypectomy

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • At least 21 years of age;
  • Willing to give consent and comply with evaluation and treatment schedule;
  • Approved for polypectomy per standard preoperative endoscopic evaluation;
  • Established indication for a procedure greater than colonoscopy and colonic polypectomy. This will include polyps not suitable for current practice (snare procedure) endoscopic resection by nature of size or location, in which an intestinal resection, laparoscopic-assisted polypectomy is required;
  • Surgical area viewable with laparoscopy.

Exclusion Criteria:

  • Physical or psychological condition which would impair study participation;
  • Unable or unwilling to attend follow-up visits and examinations;
  • Concurrent surgical procedure;
  • Pregnancy;
  • A polyp which appears to be an invasive cancer, even with negative pathology;
  • A polyp with biopsies suspicious for invasive cancer;
  • Participation in any other investigational device or drug study within 30 days prior to enrollment; or
  • Any condition which precludes compliance with the study.

Sites / Locations

  • University Hospitals, Case Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Enrolled Subjects treated with TAS device

Arm Description

All enrolled subjects treated with the Tissue Apposition System (TAS) device

Outcomes

Primary Outcome Measures

Numbers of Participants With Successful Deployment of Tissue Apposition System (TAS)
Number of enrolled subjects (participants) treated with successful deployment of the Tissue Apposition System (TAS) device.

Secondary Outcome Measures

Numbers of Participants With Successful Deployments of Tissue Anchors and Associated Knotting Element for Tissue Closure Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition.
The total number of participants with successful deployments of tissue anchors and associated knotting elements for tissue closure post-Endoscopic Mucosal Resection (EMR) tissue apposition and achieving defect closure.
Number of Participants With Durable Tissue Appositions at Three Months Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition

Full Information

First Posted
November 2, 2007
Last Updated
April 20, 2010
Sponsor
Ethicon Endo-Surgery
search

1. Study Identification

Unique Protocol Identification Number
NCT00553436
Brief Title
Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy
Official Title
Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy
Study Type
Interventional

2. Study Status

Record Verification Date
April 2010
Overall Recruitment Status
Completed
Study Start Date
November 2007 (undefined)
Primary Completion Date
April 2009 (Actual)
Study Completion Date
April 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Ethicon Endo-Surgery

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to show that the surgical site in the bowel wall can be sewn closed in the colon or intestine, with a new sewing device after removal of a benign polyp according to standard of care.
Detailed Description
Polypectomy is the medical term for removing polyps. Polyps are abnormal like growths that protrude into the lining of the bowel. Because a polyp cannot always be removed by a snare, the usual and simplest method, (for example, it may be too flat), a doctor (colorectal surgeon) may perform a polypectomy using a technique called Endoscopic Mucosal Resection (EMR). Endoscopic Mucosal Resection (EMR)is based on the concept that endoscopy (looking at the inside of your colon with an instrument called a colonoscope) provides visualization and access to the innermost lining of the gastrointestinal tract, where a polyp originates. The Endoscopic Mucosal Resection (EMR)performed during this study will be standard of care according to the current practice at University Hospitals of Cleveland. Following polyp removal, the study procedure will be performed. A medical device is being evaluated to help with this procedure by closing the wound that remains after the polyp is removed without performing an open surgical operation. This involves suturing (sewing) the tissue back together with a Tissue Apposition System (TAS). This is also called tissue approximation. The sewing device being evaluated has been cleared by the Food and Drug Administration (FDA). Up to 20 men and women, at least 21 years of age, requiring removal of a colonic or rectal polyp that cannot be removed by traditional colonic polypectomy, will be asked to enroll in the study. Following polyp removal, these patients will have the remaining tissue area closed using the study sewing device. Participation in this study will last approximately three months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Polyps
Keywords
colon, rectum, polyp, EMR, Established indication for a procedure greater than colonoscopy and colonic polypectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
7 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Enrolled Subjects treated with TAS device
Arm Type
Experimental
Arm Description
All enrolled subjects treated with the Tissue Apposition System (TAS) device
Intervention Type
Device
Intervention Name(s)
Tissue Apposition System (TAS) Device
Intervention Description
Closure of defect following polypectomy using the Tissue Apposition System (TAS) Device.
Primary Outcome Measure Information:
Title
Numbers of Participants With Successful Deployment of Tissue Apposition System (TAS)
Description
Number of enrolled subjects (participants) treated with successful deployment of the Tissue Apposition System (TAS) device.
Time Frame
At The Time of Surgery
Secondary Outcome Measure Information:
Title
Numbers of Participants With Successful Deployments of Tissue Anchors and Associated Knotting Element for Tissue Closure Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition.
Description
The total number of participants with successful deployments of tissue anchors and associated knotting elements for tissue closure post-Endoscopic Mucosal Resection (EMR) tissue apposition and achieving defect closure.
Time Frame
3 month follow-up
Title
Number of Participants With Durable Tissue Appositions at Three Months Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition
Time Frame
3 month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: At least 21 years of age; Willing to give consent and comply with evaluation and treatment schedule; Approved for polypectomy per standard preoperative endoscopic evaluation; Established indication for a procedure greater than colonoscopy and colonic polypectomy. This will include polyps not suitable for current practice (snare procedure) endoscopic resection by nature of size or location, in which an intestinal resection, laparoscopic-assisted polypectomy is required; Surgical area viewable with laparoscopy. Exclusion Criteria: Physical or psychological condition which would impair study participation; Unable or unwilling to attend follow-up visits and examinations; Concurrent surgical procedure; Pregnancy; A polyp which appears to be an invasive cancer, even with negative pathology; A polyp with biopsies suspicious for invasive cancer; Participation in any other investigational device or drug study within 30 days prior to enrollment; or Any condition which precludes compliance with the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Conor P Delaney, MD MCh PhD FRCSI FACS
Organizational Affiliation
University Hospitals Cleveland Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospitals, Case Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
20438900
Citation
Agrawal D, Chak A, Champagne BJ, Marks JM, Delaney CP. Endoscopic mucosal resection with full-thickness closure for difficult polyps: a prospective clinical trial. Gastrointest Endosc. 2010 May;71(6):1082-8. doi: 10.1016/j.gie.2009.12.036.
Results Reference
derived

Learn more about this trial

Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy

We'll reach out to this number within 24 hrs